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Abstract: The present study introduces a method for determining the labile iron pool (LIP) in human lymphocytes. It is 
measured using the probe CP655, the ﬂ  uorescence of which is stoichiometrically quenched by the addition of iron. The 
intracellular CP655 ﬂ  uorescence in lymphocytes was quenched by increasing intracellular iron concentrations using the 
highly lipophilic 8-hydroxyquinoline iron complex. Intracellular ﬂ  uorescence quenching, mediated by the physiological 
intracellular labile iron, can be recovered on the addition of excess membrane-permeable iron chelator, CP94. The intracel-
lular probe concentration was measured using laser scanning microscopy. An ex situ calibration was performed in a “cyto-
solic” medium based on the determined intracellular CP655 concentration and probe ﬂ  uorescence quenching in the presence 
of iron. The concentration of the LIP of healthy human lymphocytes was determined to be 0.57 ± 0.27 µM. The use of the 
ﬂ  uorescent probe CP655 renders it possible to record the time course of iron uptake and iron chelation by CP94 in single 
intact lymphocytes.
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Introduction
In the normal individual, intracellular iron levels are under extremely tight control. However, when the 
iron status is changed, such as during periods of regular blood transfusion, iron in excess of functional 
requirements is present in the “labile iron pool” (LIP) which readily donates iron to ferritin. In principle, 
this loosely bound iron in living cells is able to redox-cycle between the two common oxidation states, 
thereby resulting in free radicals such as superoxide and the hydroxyl radical, which can damage 
biomolecules including DNA and lipids (Halliwell and Gutteridge, 1999). In order to quantify the LIP, 
a number of methods (Kozlov et al. 1992; Stuhne-Sekalec et al. 1992; Nielsen et al. 1993; Evans and 
Halliwell, 1994) including ﬂ  uorescence spectroscopy (Zanninelli et al. 2002; Breuer et al. 1995; Petrat 
et al. 1999, 2000; Stäubli and Boelsterli, 1998; Loyevsky et al. 1999; Kakhlon et al. 2001; Darbari et al. 
2003) have been introduced. Although progress has been made in recent years towards the successful 
application of ﬂ  uorescent indicators for the determination of the intracellular labile iron pool in hepa-
tocytes (Petrat et al. 1999, 2000; Stäubli and Boelsterli, 1998) and erythrocytes (Loyevsky et al. 1999; 
Kakhlon et al. 2001; Darbari et al. 2003), the LIP of lymphocytes has been hardly studied. Lymphocytes 
are present in the systemic circulation and as such experience continual exposure to relatively high 
oxygen concentrations leaving the rise of iron-dependent free radical formation. Gackowski et al. 2002 
have reported a method to measure the lymphocyte chelatable iron pool based on the ﬂ  uorescent probe 
calcein. However, there are several disadvantages associated with this method, namely its lack of selec-
tivity and the requirement to use ester analogues in order to achieve sufﬁ  cient cellular uptake. We have 
recently reported the synthesis of several ﬂ  uorescent probes containing 3-hydroxypyridin-4-one (HPO), 
which have similar iron-binding properties to that of typical HPOs and contain a ﬂ  uorescent reporter 
group that undergoes quenching on interaction with iron (Ma et al. 2004, 2005, 2006), and found 7-
diethylamino-N-((5-hydroxy-6-methyl-4-oxo-1,4-dihydropyridin-3-yl)methyl)-N-methyl-2-oxo-2H-
chromen-3-carboxamide (CP655) to be the most sensitive to the presence of iron. Therefore, in the 
present work we study the suitability of the HPO ﬂ  uorescent iron indicator CP655 to selectively chelate 
and quantify the labile iron pool of isolated human lymphocytes.62
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Materials and Methods
Materials
RPMI-1640 medium, fetal calf serum (FCS), ferrous 
ammonium sulfate, ferric chloride, Chelex 100, L-
ascorbic acid, glutathione, sodium citrate dihydrate, 
D-(+)-glucose, 8-hydroxyquinoline, poly-L-lysine 
and propidium iodide were obtained from Sigma-
Aldrich (Steinheim, Germany). Ficoll-Paque was 
from Pharmacia (Piscataway, NJ). Dimethyl sulf-
oxide (DMSO), potassium chloride, di-sodium 
hydrogen phosphate dihydrate, magnesium chloride 
hexahydrate and imidazole were purchased from 
Merck (Darmstadt, Germany). Falcon cell culture 
ﬂ  asks and cell culture-grade Petri dishes came from 
Becton Dickinson (Heidelberg, Germany) and glass 
coverslips were from Assistant (Sondheim/Röhn, 
Germany). Polypropylene tubes for centrifugation 
came from Nunc (Wiesbaden, Germany). The iron 
chelator 1, 2-diethy-3-hydroxy-pyridin-4-one 
(CP94) was synthesized and characterized as 
reported by Dobbin et al. (1993). The ﬂ  uorescent 
probe CP655 was synthesized as previously reported 
(Ma et al. 2004) and has been identiﬁ  ed by nuclear 
magnetic resonance (NMR) and the purity assessed 
by elemental analysis.
Isolation of lymphocytes
Blood (20 ml) from healthy donors (male members 
of the institute, 25–35 years old) was collected in 
two 10 ml sodium heparin preservative-free vacu-
tainer tubes, immediately transferred to a 50 ml 
falcon tube and diluted with an equal volume (20 ml) 
of RPMI-1640 medium. 10 ml of this diluted fresh 
whole blood was then layered over 4.5 ml of Ficoll-
Paque (FP) and centrifuged (450 × g, 25 °C) for 30 
min. The supernatant was aspirated down to approx-
imately 1 cm above the Ficoll-Paque layer. The 
peripheral blood mononuclear cell (PBMC) layer, 
containing lymphocytes, was transferred to a 15 ml 
polypropylene tube which contained 10 ml RPMI 
with 5% FCS (25 °C). Then the cells were centri-
fuged (15 min at 450 × g, 25 °C) and the supernatant 
aspirated leaving a ﬁ  nal volume of 1ml; the lympho-
cytes were resuspended in 1 ml warm (37 °C) Hanks’ 
balanced salt solution (HBSS; 137 mM NaCl, 5.4 
mM KCl, 1 mM CaCl2, 0.5 mM MgCl2, 0.4 mM 
KH2PO4, 0.4 mM MgSO4, 0.3 mM Na2HPO4, 25 
mM Hepes, pH 7.4) and transferred to a 15 ml 
polypropylene tube. Cells were used for the 
measurements within 6 h.
Determination of the intracellular 
CP655 ﬂ  uorescence intensity
Freshly isolated lymphocytes were seeded at a density 
of 1.5 × 10
7 cells/ml on a glass coverslip that has been 
coated with poly-lysine (5 µg/cm
2) in a modiﬁ  ed Pentz 
chamber. After 10–15 min of incubation at 37 °C, the 
adherent cells were washed twice with HBSS and 
loaded with CP655 (30 µM; clogP of iron free ligand 
at 0.43 and of iron complex at 0.29) for 10 min in 
HBSS (37 °C). Lymphocytes were then carefully 
washed three times with HBSS and 6 ml of fresh 
HBSS (37 °C) remained within the chamber during 
measurements. The ﬂ  uorescence measurements were 
performed using an inverted microscope (Axiovert 
135 TV, Zeiss, Oberkochen, Germany) equipped with 
the Attofluor imaging system (Atto Instruments, 
Rockville, MD). The CP655-loaded cells were excited 
at 425 ± 22.5 nm and the emission was monitored at 
450–490 nm every 60 s using a bandpass ﬁ  lter. The 
exciting light was attenuated to 4% using gray ﬁ  lters 
in order to avoid photochemical damaging of the cells. 
The intracellular chelatable iron pool was manipulated 
5 min after the beginning of the measurements by 
adding either the membrane-permeable iron(III)-8-
hydroxyquinoline complex (15 µM) that had been 
freshly prepared from stock solutions of ferric chloride 
(10 mM) and 8-hydroxyquinoline (8-HQ; 20 mM) in 
dimethyl sulfoxide (DMSO) or by the membrane-
permeable iron chelator, CP94 (1 mM; clogP of iron 
free ligand at 0.16 and of iron complex at -0.40), which 
had been freshly prepared by dissolving CP94 (100 
mM) in 18 mΩ Millipore water. CP655 ﬂ  uorescence 
was then recorded until it stabilized (Fig. 1). The 
autoﬂ  uorescence from a parallel experiment with 
unloaded control lymphocytes as obtained using same 
instrument settings was set at 0% probe ﬂ  uorescence 
intensity. The ﬂ  uorescence intensity of the probe-
loaded lymphocytes at the end of the experiment with 
CP94 was set at 100% and used to calculate the rela-
tive initial CP655 ﬂ  uorescence intensity of the cells 
(Fig. 1). Since the measurements were performed on 
the single cell level, it was possible to differentiate 
lymphocytes from other PBMC, like monocytes. 
Solely lymphocytes were selected for evaluation.
Determination of the intracellular 
probe concentration
Cells were loaded with CP655 as described above. 
After washing the lymphocytes with HBSS, ﬂ  uores-
cence measurements were performed using a laser 
scanning microscope (LSM 510, Zeiss, Oberkochen, 63
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Germany) equipped with an argon laser. The intracel-
lular fluorescence of CP655, after being fully 
dequenched by CP94 (1 mM), was excited at 458 nm 
and observed through a 475 nm bandpass ﬁ  lter. The 
ﬂ  uorescence measurements were performed in a focal 
plane 5–10 µm above the surface of the glass cover-
slip. At the end of the experimental procedures the 
uptake of the vital dye propidium iodide was routinely 
determined in order to detect loss of cell viability. The 
red ﬂ  uorescence of propidium iodide excited at 543 
nm using the helium/neon laser was collected through 
a 560 nm long-pass ﬁ  lter; nuclear staining of few dead 
cells suggested that the lymphocytes studied were not 
proliferating. This focal plane and identical scanning 
parameters for cellular CP655 ﬂ  uorescence were used 
for scanning the cellular autoﬂ  uorescence as well as 
the fluorescence of a Chelex 100-treated 
tris(hydroxymethyl)amino–methane buffer (Tris-
buffer, pH 7.4, 37 °C) containing known concentra-
tions of CP655. The intracellular concentration of 
CP655 in lymphocytes was determined from the 
difference in ﬂ  uorescence of CP655-loaded lympho-
cytes and unloaded cells (ΔF) compared with the 
ﬂ  uorescence of iron-free CP655 standards in the Tris-
buffer.
Ex situ calibration for the determination 
of human lymphocyte LIP
The quenching effect of Fe(II) on CP655 ﬂ  uorescence 
in a medium designed to simulate the composition of 
the cytosol (37 
oC) was determined using digital ﬂ  uo-
rescence microscopy at the same settings as used for 
the cellular measurements (see above). This cytosolic 
medium contained 100 mM KCl, 5 mM Na2HPO4, 4 
mM ATP, 2 mM MgCl2, 6.85 mM glucose, 0.138 mM 
pyruvate, 1.5 mM L-lactate, 0.23 mM sodium citrate, 
2.99 mM potassium phosphate, the amino acid 
composition of Eagle’s minimum essential medium, 
2 mM ascorbic acid, 4.5 mM glutathione (GSH) and 
10 mM imidazole, pH 7.2. Aliquots (2 ml) of the 
medium were placed on a glass coverslip within a 
modiﬁ  ed Pentz chamber, and CP655 at a ﬁ  nal concen-
tration of 6 µM, i.e. the intracellular concentration of 
the probe (see below), was added and mixed with the 
medium. After the initial stable ﬂ  uorescence had been 
recorded, known concentrations of Fe(II) were added 
from a freshly prepared stock solution (0.5 mM ferrous 
ammonium sulfate plus 10 mM L-ascorbic acid). The 
addition of iron was continued until no additional 
ﬂ  uorescence quenching could be observed.
Results and Discussion
CP655 ﬂ  uorescence in lymphocytes could be both 
decreased and increased by the addition of iron and 
iron chelators, respectively. The addition of 
iron(III)-8-hydroxyquinoline (1:2) at a concentra-
tion of 15 µM almost completely quenched the 
intracellular probe fluorescence (Fig. 1). In 
controls, i.e. no addition of the iron complex, the 
Figure 1. Effect of either iron(III) or CP94 on the intracellular ﬂ  uorescence of CP655-loaded lymphocytes. Subsequent to the measurement 
of the initial ﬂ  uorescence (λex = 425 ± 22.5 nm, λem = 450–490 nm) of lymphocytes that had been loaded with 30 µM CP655 (for 10 min, in 
HBSS, 37 °C), either the iron complex (ferric chloride:8-hydroxyquinoline = 15 µM : 30 µM) or the strong iron chelator, CP94 (1 mM), was 
added to the supernatant and the ﬂ  uorescence (in arbitrary units, a.u.) was recorded using digital ﬂ  uorescence microscopy. In addition, the 
autoﬂ  uorescence from a parallel incubation of unloaded lymphocytes was recorded at the same instrument settings. The autoﬂ  uorescence 
was set at 0% ﬂ  uorescence and ﬂ  uorescence after dequenching by CP94 at 100%. Each trace shown is the average of 15–20 cells and is 
representative of 6 experiments. 
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intracellular probe ﬂ  uorescence remained stable 
for at least 30 min. In other experiments, the addi-
tion of a large excess of the membrane-permeable 
iron chelator, CP94 (1 mM, ﬁ  nal concentration), 
signiﬁ  cantly enhanced the intracellular probe ﬂ  uo-
rescence (Fig. 1). The intracellular probe ﬂ  uores-
cence in lymphocytes was found to be relatively 
weak and the probe dequenching to be relatively 
low when 10 µM probe was used for cellular 
loading. Therefore, we increased the CP655 
loading concentration to 20, 30, 40 and 50 µM, 
respectively, and found that a maximum ﬂ  uores-
cence increase in lymphocytes was obtained when 
30 µM of the probe had been used (data not shown). 
In contrast to low intracellular probe concentra-
tions, which may be insufﬁ  cient to completely 
chelate the cellular labile iron, high intracellular 
probe concentrations may promote probe leakage 
from the cells during the time-course of the 
measurements, rendering the system rather insen-
sitive towards the detection of the small pool of 
intracellular chelatable iron. Thus, 30 µM CP655 
was adopted as an optimal loading concentration 
for the determination of the LIP in lymphocytes. 
This loading concentration of CP655 did not inﬂ  u-
ence the cell viability as judged by the vital dye, 
propidium iodide, which was added to the lympho-
cytes at the end of the experiments. 
When different CP655 concentrations (0–20 
µM, iron-free probe) in a cell-free system were 
plotted versus their ﬂ  uorescence intensity as deter-
mined using laser scanning microscopy, the ﬂ  uo-
rescence intensity was found to increase in a 
linearly proportional fashion with the concentra-
tion of the probe standards (data not shown). The 
total cellular ﬂ  uorescence (Ftotal = CP655 ﬂ  uores-
cence + cellular autoﬂ  uorescence) was measured 
5–10 min after the addition of an excess of CP94 
(1 mM) to the supernatant (Fig. 2A). The difference 
(ΔF) between Ftotal and the autoﬂ  uorescence of 
unloaded lymphocytes as determined at the same 
instrument setting (Fauto) (Fig. 2B) represented the 
intracellular CP655 ﬂ  uorescence (FCP655). Based 
on FCP655 and the above standard curve, a mean 
CP655 concentration of 5.9 ± 1.5 µM was deter-
mined in human lymphocytes.
CP655 at a concentration of 6 µM, i.e. the intra-
cellular probe concentration, was used to perform 
an ex situ calibration procedure. Calibrations were 
performed using digital ﬂ  uorescence microscopy 
and a cytosolic medium (37 °C) which has been 
designed to simulate the cytosol composition 
(Fig. 3A). The ﬂ  uorescence signal of the iron-free 
probe (6 µM) was set at 100% probe ﬂ  uorescence 
intensity, the autoﬂ  uorescence of the cytosolic 
medium in the absence of CP655 was determined 
at the same instrument settings and set at 0% 
(Fig. 3B). Small amounts of iron (II) were added 
to the calibration medium and recordings continued 
until the progressive quenching of CP655 ﬂ  uores-
cence leveled off, suggesting that a steady state 
had been reached (Fig. 3A). Based on this ex situ 
calibration curve and relative intracellular ﬂ  uores-
cence intensity of the initial CP655 ﬂ  uorescence 
of 79 ± 8% (Fig. 1), the concentration of intracel-
lular chelatable iron in lymphocytes was deter-
mined to be 0.57 ± 0.27 µM (n = 8). This value is 
well in line with the value of 0.53 ± 0.58 µM LIP 
reported for healthy human lymphocytes by Gack-
owski et al. (2002), and comparable to the levels 
that have been determined in monocytes (Epsztejn 
et al. 1997), but much less than the hepatocyte LIP 
(5.4 ± 1.3 µM) determined in our previous report 
(Ma et al. 2006). The ﬁ  nding that there is good 
agreement with the results reported by Gackowski 
et al. (2002) for lymphocytes, would indicate that, 
for this type of cell, the use of calcein provides a 
realistic estimate of LIP.
Previously, we have reported that intracellular 
ligands for iron like phosphates compete with low 
CP655 concentrations for iron binding (Ma et al. 
2006). However, it in unlikely that these ligands 
strongly affected the intracellular determination of 
the lymphocyte LIP as reported here, since the ex 
situ calibrations were performed in a medium 
designed to simulate the composition of the 
cytosol, i.e. in a medium containing physiological 
concentrations of cellular ligands for iron.
In conclusion, in the present study we intro-
duce an assay for the determination of the LIP in 
single intact lymphocytes based on a combination 
of digital ﬂ  uorescence microscopy and laser scan-
ning microscopy. This assay depends on the 
speciﬁ  c quenching of CP655 by cellular chelat-
able iron. The method described herein has the 
advantages of simplicity, relatively low cost, high 
sensitivity and permits measurement at the single 
cell level. CP655, a novel ﬂ  uorescent iron indi-
cator, has been found to be highly sensitive to the 
presence of intracellular chelatable iron and does 
not cause obvious cytotoxic effects. In contrast 
to calcein (Hasinoff, 2003), the indicator is not 
prone to oxidative damage in the presence of 
ferrous labile iron. These properties render it suit-65
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Figure 2. Intracellular distribution of CP655 ﬂ  uorescence in human lymphocytes. Cells were loaded with CP655 by incubation (30 µM for 
10 min in HBSS, 37 °C) and the intracellular ﬂ  uorescence was scanned using laser scanning microscopy (λex =458nm, λem = 475 nm). (A) 
Intracellular ﬂ  uorescence of CP655-loaded cells 10 min after addition of CP94 (1 mM); (B) autoﬂ  uorescence of unloaded lymphocytes at 
same instrument settings.
able for monitoring the chelatable iron pool in 
various cell-types and therefore of providing 
information on the efﬁ  cacy of different chelators 
currently under investigation for treatment of iron 
overload.
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